<?xml version="1.0" encoding="UTF-8"?>
<p id="p0015">According to World Health Organization suggestions, nasal swabs (UTM viral transportÂ®, Copan Italia S.p.a) from all suspected cases and their contacts were tested with at least two real-time reverse transcription PCR (RT-PCR) assays targeting different genes (
 <italic>E</italic> and 
 <italic>RdRp</italic>) of SARS-CoV-2 [
 <xref rid="bib1" ref-type="bibr">1</xref>]. In addition, nasal swabs were also evaluated with a novel quantitative RT-PCR targeting an additional SARS-CoV-2 gene (
 <italic>M</italic>) developed in our laboratory (details provided upon request).
</p>
